Neutropenia ultrasound: Difference between revisions
m (Template) |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ Neutropenia }} | {{ Neutropenia }} | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}} {{DG}} | ||
==Overview== | ==Overview== | ||
[[Neutropenia]] is not identified on or correlated with any particular imaging. In the cases of [[neutropenic fever]], imaging findings are dependent upon the source of the [[fevers]]. | |||
==Ultrasound== | ==Ultrasound== | ||
Initial evaluation for [[neutropenic fever]] should include a chest radiograph to evaluate for pulmonary infiltrates or effusions. Further imaging, such as ultrasound, CT, or MRI scans, are indicated depending upon presenting symptoms and physical examination findings.<ref name="PMID21258094">{{cite journal |author=Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR; Infectious Diseases Society of America. |title=Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america|journal=Clin Infect Dis. |volume=52 |issue=4 |pages=e56-95 |year=2011 |pmid=21258094 |doi=|url=http://www.ncbi.nlm.nih.gov/pubmed/21258094}}</ref> | |||
==References== | ==References== | ||
Latest revision as of 00:43, 17 November 2016
|
Neutropenia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neutropenia ultrasound On the Web |
|
American Roentgen Ray Society Images of Neutropenia ultrasound |
|
Risk calculators and risk factors for Neutropenia ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Daniel A. Gerber, M.D. [2]
Overview
Neutropenia is not identified on or correlated with any particular imaging. In the cases of neutropenic fever, imaging findings are dependent upon the source of the fevers.
Ultrasound
Initial evaluation for neutropenic fever should include a chest radiograph to evaluate for pulmonary infiltrates or effusions. Further imaging, such as ultrasound, CT, or MRI scans, are indicated depending upon presenting symptoms and physical examination findings.[1]
References
- ↑ Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR; Infectious Diseases Society of America. (2011). "Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america". Clin Infect Dis. 52 (4): e56–95. PMID 21258094.